Product Information
LITHIUM CARBONATE ER 300 MG TB is a generic product labeled by Heritage Pharmaceuticals Inc., priced at $0.1959 per EA under NDC 23155076301. Its NADAC has been published 289 times since Feb 10, 2021.
FDA first approved this application on Sep 29, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
300 mg/1
Manufacturer
Heritage Pharmaceuticals Inc.NDC
23155076301
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LITHIUM CARBONATEApproval Type
Generic (ANDA)
FDA Application
ANDA205532FDA Approved
9/29/2016
TE Code
AB
On Market Since
10/20/2020
Pharmacological Classes
Price Statistics
The NADAC for LITHIUM CARBONATE ER 300 MG TB has been published 289 times since Feb 10, 2021, and over the history we have for it it has risen 16.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1959 per EA |
|---|---|
| All-time high | $0.2271 (Nov 13, 2024) |
| All-time low | $0.1260 (Dec 21, 2022) |
| 52-week high | $0.2097 |
| 52-week low | $0.1959 |
| Median price | $0.1621 |
| Average price | $0.1713 |
| Largest weekly change | +33.8% (Jun 19, 2024) |
| Weeks tracked | 289 |
| Tracking since | Feb 10, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Lithium carbonate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LITHIUM CARBONATE ER 300 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for LITHIUM CARBONATE ER 300 MG TB, manufactured by Heritage Pharmaceuticals Inc., is $0.1959 per EA (NDC 23155076301), effective Aug 19, 2026.
How has the price of LITHIUM CARBONATE ER 300 MG TB changed over time?
Over the history we have for it, the NADAC for LITHIUM CARBONATE ER 300 MG TB has risen 16.1%. It has been tracked across 289 weekly CMS publications since Feb 10, 2021.
What are the highest and lowest recorded NADAC prices for LITHIUM CARBONATE ER 300 MG TB?
Since Feb 10, 2021, the NADAC for LITHIUM CARBONATE ER 300 MG TB has ranged from a low of $0.1260 (Dec 21, 2022) to a high of $0.2271 (Nov 13, 2024), with a median of $0.1621 per EA.
Are there cheaper alternatives to LITHIUM CARBONATE ER 300 MG TB?
No other NADAC-published product currently shares the active ingredient and strength of LITHIUM CARBONATE ER 300 MG TB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures LITHIUM CARBONATE ER 300 MG TB?
LITHIUM CARBONATE ER 300 MG TB (NDC 23155076301) is labeled by Heritage Pharmaceuticals Inc., and CMS classifies it as a generic product.